A Randomized, Open-Label Study Conducted to Evaluate the Bioequivalence of Pegfilgrastim-cbqv On-Body Injector Versus Prefilled Syringe in Healthy Male Participants
posted on 2023-12-05, 17:35authored byAdis Rapid Journals on behalf of:, Hong Tang, Francesca Civoli, Suzanna Tatarewicz, Nathalie Vandenkoornhuyse, Barbara Finck
The above Graphical Abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).